BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

640 related articles for article (PubMed ID: 30507391)

  • 21. Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
    GBD 2016 Neurology Collaborators
    Lancet Neurol; 2019 May; 18(5):459-480. PubMed ID: 30879893
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The global, regional, and national burden of oesophageal cancer and its attributable risk factors in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    GBD 2017 Oesophageal Cancer Collaborators
    Lancet Gastroenterol Hepatol; 2020 Jun; 5(6):582-597. PubMed ID: 32246941
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
    GBD 2016 DALYs and HALE Collaborators
    Lancet; 2017 Sep; 390(10100):1260-1344. PubMed ID: 28919118
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Global, regional, and national burden of stroke, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
    GBD 2016 Stroke Collaborators
    Lancet Neurol; 2019 May; 18(5):439-458. PubMed ID: 30871944
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.
    GBD 2015 DALYs and HALE Collaborators
    Lancet; 2016 Oct; 388(10053):1603-1658. PubMed ID: 27733283
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Global, regional, and national burden of meningitis and its aetiologies, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.
    GBD 2019 Meningitis Antimicrobial Resistance Collaborators
    Lancet Neurol; 2023 Aug; 22(8):685-711. PubMed ID: 37479374
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estimates of global, regional, and national morbidity, mortality, and aetiologies of diarrhoeal diseases: a systematic analysis for the Global Burden of Disease Study 2015.
    GBD Diarrhoeal Diseases Collaborators
    Lancet Infect Dis; 2017 Sep; 17(9):909-948. PubMed ID: 28579426
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Global, regional, and national burden of migraine and tension-type headache, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
    GBD 2016 Headache Collaborators
    Lancet Neurol; 2018 Nov; 17(11):954-976. PubMed ID: 30353868
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.
    GBD 2015 Disease and Injury Incidence and Prevalence Collaborators
    Lancet; 2016 Oct; 388(10053):1545-1602. PubMed ID: 27733282
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Global, regional, and national burden of motor neuron diseases 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
    GBD 2016 Motor Neuron Disease Collaborators
    Lancet Neurol; 2018 Dec; 17(12):1083-1097. PubMed ID: 30409709
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.
    GBD 2019 Risk Factors Collaborators
    Lancet; 2020 Oct; 396(10258):1223-1249. PubMed ID: 33069327
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Global, regional, and national burden of Alzheimer's disease and other dementias, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
    GBD 2016 Dementia Collaborators
    Lancet Neurol; 2019 Jan; 18(1):88-106. PubMed ID: 30497964
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    GBD 2017 Inflammatory Bowel Disease Collaborators
    Lancet Gastroenterol Hepatol; 2020 Jan; 5(1):17-30. PubMed ID: 31648971
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950-2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021.
    GBD 2021 Demographics Collaborators
    Lancet; 2024 May; 403(10440):1989-2056. PubMed ID: 38484753
    [TBL] [Abstract][Full Text] [Related]  

  • 35. National disability-adjusted life years (DALYs) for 257 diseases and injuries in Ethiopia, 1990-2015: findings from the global burden of disease study 2015.
    Misganaw A; Melaku YA; Tessema GA; Deribew A; Deribe K; Abera SF; Dessalegn M; Lakew Y; Bekele T; Haregu TN; Amare AT; Gedefaw M; Mohammed M; Yirsaw BD; Damtew SA; Achoki T; Blore J; Krohn KJ; Assefa Y; Kifle M; Naghavi M
    Popul Health Metr; 2017 Jul; 15(1):28. PubMed ID: 28732542
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
    GBD 2016 Risk Factors Collaborators
    Lancet; 2017 Sep; 390(10100):1345-1422. PubMed ID: 28919119
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950-2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019.
    GBD 2019 Demographics Collaborators
    Lancet; 2020 Oct; 396(10258):1160-1203. PubMed ID: 33069325
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Global, regional, and national burden of multiple sclerosis 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
    GBD 2016 Multiple Sclerosis Collaborators
    Lancet Neurol; 2019 Mar; 18(3):269-285. PubMed ID: 30679040
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Global, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.
    GBD 2019 Stroke Collaborators
    Lancet Neurol; 2021 Oct; 20(10):795-820. PubMed ID: 34487721
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study.
    ; Fitzmaurice C; Allen C; Barber RM; Barregard L; Bhutta ZA; Brenner H; Dicker DJ; Chimed-Orchir O; Dandona R; Dandona L; Fleming T; Forouzanfar MH; Hancock J; Hay RJ; Hunter-Merrill R; Huynh C; Hosgood HD; Johnson CO; Jonas JB; Khubchandani J; Kumar GA; Kutz M; Lan Q; Larson HJ; Liang X; Lim SS; Lopez AD; MacIntyre MF; Marczak L; Marquez N; Mokdad AH; Pinho C; Pourmalek F; Salomon JA; Sanabria JR; Sandar L; Sartorius B; Schwartz SM; Shackelford KA; Shibuya K; Stanaway J; Steiner C; Sun J; Takahashi K; Vollset SE; Vos T; Wagner JA; Wang H; Westerman R; Zeeb H; Zoeckler L; Abd-Allah F; Ahmed MB; Alabed S; Alam NK; Aldhahri SF; Alem G; Alemayohu MA; Ali R; Al-Raddadi R; Amare A; Amoako Y; Artaman A; Asayesh H; Atnafu N; Awasthi A; Saleem HB; Barac A; Bedi N; Bensenor I; Berhane A; Bernabé E; Betsu B; Binagwaho A; Boneya D; Campos-Nonato I; Castañeda-Orjuela C; Catalá-López F; Chiang P; Chibueze C; Chitheer A; Choi JY; Cowie B; Damtew S; das Neves J; Dey S; Dharmaratne S; Dhillon P; Ding E; Driscoll T; Ekwueme D; Endries AY; Farvid M; Farzadfar F; Fernandes J; Fischer F; G/Hiwot TT; Gebru A; Gopalani S; Hailu A; Horino M; Horita N; Husseini A; Huybrechts I; Inoue M; Islami F; Jakovljevic M; James S; Javanbakht M; Jee SH; Kasaeian A; Kedir MS; Khader YS; Khang YH; Kim D; Leigh J; Linn S; Lunevicius R; El Razek HMA; Malekzadeh R; Malta DC; Marcenes W; Markos D; Melaku YA; Meles KG; Mendoza W; Mengiste DT; Meretoja TJ; Miller TR; Mohammad KA; Mohammadi A; Mohammed S; Moradi-Lakeh M; Nagel G; Nand D; Le Nguyen Q; Nolte S; Ogbo FA; Oladimeji KE; Oren E; Pa M; Park EK; Pereira DM; Plass D; Qorbani M; Radfar A; Rafay A; Rahman M; Rana SM; Søreide K; Satpathy M; Sawhney M; Sepanlou SG; Shaikh MA; She J; Shiue I; Shore HR; Shrime MG; So S; Soneji S; Stathopoulou V; Stroumpoulis K; Sufiyan MB; Sykes BL; Tabarés-Seisdedos R; Tadese F; Tedla BA; Tessema GA; Thakur JS; Tran BX; Ukwaja KN; Uzochukwu BSC; Vlassov VV; Weiderpass E; Wubshet Terefe M; Yebyo HG; Yimam HH; Yonemoto N; Younis MZ; Yu C; Zaidi Z; Zaki MES; Zenebe ZM; Murray CJL; Naghavi M
    JAMA Oncol; 2017 Apr; 3(4):524-548. PubMed ID: 27918777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.